Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report.
Jessica R Howard-AndersonStephanie M PouchMary Elizabeth SextonAneesh K MehtaAndrew L SmithGeorge M LyonRachel Friedman-MoracoPublished in: Open forum infectious diseases (2019)
Left ventricular assist device infections (LVADIs) are common but challenging to treat, often requiring prolonged courses of intravenous antibiotics. Dalbavancin could have a role in treating patients with chronic LVADIs given its less frequent dosing requirements. Here, we illustrate a case in which dalbavancin was used as suppressive therapy for an LVADI for greater than 7 months.
Keyphrases